DE60033649D1 - Verbindungen und therapeutische methoden - Google Patents

Verbindungen und therapeutische methoden

Info

Publication number
DE60033649D1
DE60033649D1 DE60033649T DE60033649T DE60033649D1 DE 60033649 D1 DE60033649 D1 DE 60033649D1 DE 60033649 T DE60033649 T DE 60033649T DE 60033649 T DE60033649 T DE 60033649T DE 60033649 D1 DE60033649 D1 DE 60033649D1
Authority
DE
Germany
Prior art keywords
compounds
therapeutic methods
treatment
diseases
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033649T
Other languages
English (en)
Inventor
Rodney W Rickards
Geoffrey D Smith
Kiaran Kirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ0373A external-priority patent/AUPQ037399A0/en
Priority claimed from AUPQ0506A external-priority patent/AUPQ050699A0/en
Application filed by Australian National University filed Critical Australian National University
Application granted granted Critical
Publication of DE60033649D1 publication Critical patent/DE60033649D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60033649T 1999-05-14 2000-05-12 Verbindungen und therapeutische methoden Expired - Lifetime DE60033649D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ0373A AUPQ037399A0 (en) 1999-05-14 1999-05-14 Novel compounds and therapeutic methods
AUPQ0506A AUPQ050699A0 (en) 1999-05-21 1999-05-21 Novel compounds and therapeutic methods-ii
PCT/AU2000/000458 WO2000069856A1 (en) 1999-05-14 2000-05-12 Compounds and therapeutic methods

Publications (1)

Publication Number Publication Date
DE60033649D1 true DE60033649D1 (de) 2007-04-12

Family

ID=25646057

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033649T Expired - Lifetime DE60033649D1 (de) 1999-05-14 2000-05-12 Verbindungen und therapeutische methoden

Country Status (7)

Country Link
US (1) US6632822B1 (de)
EP (1) EP1178988B1 (de)
JP (1) JP2002544275A (de)
AT (1) ATE355288T1 (de)
CA (1) CA2372032A1 (de)
DE (1) DE60033649D1 (de)
WO (1) WO2000069856A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962023B2 (en) 2004-09-28 2015-02-24 Atrium Medical Corporation UV cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
WO2006036967A1 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
CA2764653C (en) 2009-06-10 2018-01-02 Chugai Seiyaku Kabushiki Kaisha Tetracyclic compounds
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
EP2606886B1 (de) 2010-08-20 2020-01-08 Chugai Seiyaku Kabushiki Kaisha Zusammensetzung umfassend eine tetrazyklische verbindung
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CA3077553C (en) 2012-09-25 2022-08-02 Chugai Seiyaku Kabushiki Kaisha Ret inhibitor
AU2015250574B2 (en) 2014-04-25 2020-07-16 Chugai Seiyaku Kabushiki Kaisha Preparation containing tetracyclic compound at high dose
CA2946268A1 (en) 2014-04-25 2015-10-29 Chugai Seiyaku Kabushiki Kaisha Crystal of tetracyclic compound
TWI718102B (zh) 2014-08-08 2021-02-11 日商中外製藥股份有限公司 ４環性化合物的非晶質體
US11077093B2 (en) 2015-01-16 2021-08-03 Chugai Seiyaku Kabushiki Kaisha Combination drug
AR116113A1 (es) 2018-09-04 2021-03-31 Chugai Pharmaceutical Co Ltd Método para fabricar un compuesto tetracíclico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743899B2 (en) 1997-07-18 2002-02-07 Georgetown University Bicyclic metabotropic glutamate receptor ligands
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists

Also Published As

Publication number Publication date
EP1178988A4 (de) 2004-10-06
CA2372032A1 (en) 2000-11-23
EP1178988A1 (de) 2002-02-13
JP2002544275A (ja) 2002-12-24
EP1178988B1 (de) 2007-02-28
US6632822B1 (en) 2003-10-14
WO2000069856A1 (en) 2000-11-23
ATE355288T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
ATE355288T1 (de) Verbindungen und therapeutische methoden
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
ME00513B (me) Azabicikloalkani kao modulatori ccr5
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
YU13301A (sh) Muskarinski agonisti i antagonisti
ES2144054T3 (es) Complejos de tri(platino).
SE0003476D0 (sv) Compounds
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE69514100T2 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
ATE306283T1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
ATE404550T1 (de) Chemische verbindungen
AU7079300A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
8332 No legal effect for de